Sign In
About ASHM | Careers | Your Cart Shoppint Cart
    Skip Navigation LinksASHM Internet Home > Resources

    Resources

    ​High Level Summit on Rising HIV, Sexually Transmissible Infections (STI) and Viral Hepatitis in Aboriginal and Torres Strait Islander Communities 

    An initiative of Aboriginal and Torres Strait Islander HIV Awareness Week (ATSIHAW), was the convening of a High Level Summit on Rising HIV, Sexually Transmissible Infections (STI) and Viral Hepatitis in Aboriginal and Torres Strait Islander Communities ('The Summit'), held in Brisbane in December 2015.

    The Summit was one of the most important meetings in Indigenous Health, BBV and STIs in more than 30 years, and was convened in recognition of the rising rates of HIV, endemic rates of STIs in many Aboriginal and Torres Strait Islander communities, as well as disproportionate rates of viral hepatitis. The Summit brought together 90 high-level stakeholders to discuss key public health and clinical priorities within Indigenous communities, culminating in a set of recommendations. 

    Download the Summit Report


    Australian Indigenous HealthInfoNet ​Resources

    Overview of Aboriginal and Torre Strait Islander Health Status 2015 (Vertical).jpgOverview of Aboriginal and Torres strait Islander health status​​

    This flagship publication providing evidence-based data to reduce harmful AOD use in Aboriginal and Torres Strait Islander communities, has proved valuable for a wide range of health professionals, policy makers and others working in this health sector in providing informat​ion about: Aboriginal and Torres Strait Islander populations; the context of Indigenous health; various measures of population health status; selected health conditions; and health risk and protective factors. It is available online and as a PDF download


    Australian Indigenous Health Review.jpgReview of Illicit Drug Use Among Aboriginal and Torres Strait Islander people 

    The Australian Indigenous Alcohol and Other Drugs Knowledge Centre has released a comprehensive review of illicit drug use among Aboriginal and Torres Strait Islander people which is freely available on the Knowledge Centre web resource. It is available online and also as a PDF download​.​​


    Review of volatile substance use among Aboriginal and Torres Strait Islander people​

    The purpose of this review is to provide a comprehensive synthesis of key information on volatile substance use (VSU) for people involved in Aboriginal and Torres Strait Islander health in Australia, and draws on a number of substantial reports and other key documents.​ It is available online.


    Surveillance Report: Infectious and congenital syphilis notifications associated with and ongoing outbreak in northern Australia

    Infectious and Congenital Syphilis Notifications.JPGThe short report, Infectious and congenital syphilis notifications associated with and ongoing outbreak in northern Australia, has been published  in the Communicable Diseases Intelligence, Volume 40 Number 1

    The Multijurisdictional Syphilis Outbreak Working Group (MJSO) was formed by the Communicable Diseases Network of Australia (CDNA) in April 2015, in response to an ongoing outbreak of syphilis among Aboriginal and Torres Strait Islander people living largely in remote and rural areas of northern Australia. Increased notifications associated with the outbreak in northern Australia were first reported in January 2011 in northwest Queensland, followed by the Northern Territory (NT) in July 2013, and the Kimberley region of Western Australia (WA) in June 2014.

    TheMJSO Communique March Meeting summarises the outbreak epidemiological data as of 29 February 2016, and the activities of the MJSO from 1 October 2015 -­ 29 February 2016.


    Resources for Aboriginal Community Controlled Health Services

    ASHM has developed a range of practical resources to assist with the management of viral hepatitis in  Aboriginal Community Controlled Health Services (ACCHS).​


    Communicare User Manual Viral Hepatitis  

    This manual was developed in collaboration with the Aboriginal Health Council of South Australia (AHCSA), and provides a comprehensive guide for best practice screening, testing and management of viral hepatitis. This manual provides step by step details for implementation of best practice within Communicare, and aims to standardise viral hepatitis management across ACCHSs nationally. 

    Click on the image to download a high-resolution version of the manual (50 MB). If you experience difficulty downloading the high-resolution file, a low-resolution version (15MB) can be downloaded here.​ This version requires Acrobat 8.0 or higher (you can download Acrobat free of charge here). This could be an option for ACCHSs with limited internet capacity (NB: screen shots will not be of the same clarity as the high-resolution file).

    Communicare Administrator Manual Viral Hepatitis

    Communicare-Administrator-Manual.JPGThis manual was developed in collaboration with the Aboriginal Health Council of South Australia (AHCSA), to enable health services using the Clinical Information System – Communicare, to make the changes necessary to be able to implement the Communicare User Manual: Viral Hepatitis. This manual provides a step-by-step to guide for Communicare Administrators to follow.

    Click on the image  to download a high-resolution version of the manual (38 MB). If you experience difficulty downloading the high-resolution file, a low-resolution version (8MB) can be downloaded here.​ This version requires Acrobat 8.0 or higher (you can download Acrobat free of charge here). This could be an option for ACCHSs with limited internet capacity (NB: screen shots will not be of the same clarity as the high-resolution file).


    Hepatitis C Team Care Plan ACCHS

    This team care plan outlines a multidisciplinary approach to managing patients with Hepatitis C. It can be used to guide HCV patient management in an ACCHSs setting and may be uploaded to patient management systems such as Communicare.

    HCV in ACCHS Model of Care

    This model of care was developed by Dr Penny Abbott of the Aboriginal Medical Service Western Sydney. The model details the roles of staff and support services in the patient journey of diagnosis and management of chronic hepatitis C in an ACCHS.

    Clinical Pathways Agreement

    This template can be used by ACCHS and hepatitis C treatment services to provide a framework for patient management arrangements including preferred methods of communication and the responsibilities of each service. The template may remain broad or be utilised to detail specific projects such as an outreach clinic or case management meetings. The role and responsibilities listed are examples which can be adapted based on the patient management protocols within each service.

    Localised HCV Decision-Making Tool

    This tool is a quick reference guide to assist in testing and diagnosis for hepatitis C. This resource outlines the roles and responsibilities for the ACCHS and specialist services. ASHM can adapt the referral processes and treatment service details for your local area.

    Please contact us for details.


    STI & BBV Testing Tool for GPs in NSW ACCHS

    This 2-sided A4-sized quick reference guide provides information on when to consider STI and blood borne virus testing, as well as information on contact tracing. It was developed and published in May 2016 by the Aboriginal Health & Medical Research Council of NSW (AH&MRC) and the NSW STI Programs Unit (NSW STIPU). 


    AH&MRC STI Resource Order Form

    The Aboriginal Health & Medical Research Council of NSW (AH&MRC) have a limited supply of FREE sexual health resources for member services to promote and encourage STI testing, HIV awareness and access to free condoms for services that work with young Aboriginal people.



    More Resources

    For people who work with Aboriginal and Torres Strait Islander people.

     

     

    Australian recommendations for the management of hepatitis C virus infection: Consensus statement 2016http://www.ashm.org.au/resources/Pages/01032016.aspxAustralian recommendations for the management of hepatitis C virus infection: Consensus statement 2016Prepared by an expert panel, this document provides guidance on epidemiology, models of care, diagnosis, pre-treatment assessment, monitoring and treatment.GP0|#dcb5bb65-47fe-4de8-bef4-63504a92e3d3;L0|#0dcb5bb65-47fe-4de8-bef4-63504a92e3d3|Booklet;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#a700ed02-fbb9-4529-9868-7e249cd119ecGP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis C;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89GP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa42016-12-19T04:38:11Z
    Decision-Making in HCV-Aug 2016http://www.ashm.org.au/resources/Pages/978-1-920773-43-4.aspxDecision-Making in HCV-Aug 2016This decision-making guide will assist primary care clinicians in the assessment, management and treatment of hepatitis C. GP0|#9ac742b4-1677-49fd-9f7a-c0e73d2957b5;L0|#09ac742b4-1677-49fd-9f7a-c0e73d2957b5|Decision Making Tool;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#a700ed02-fbb9-4529-9868-7e249cd119ecGP0|#f001df20-76bd-422b-9adc-dc3407467c1e;L0|#0f001df20-76bd-422b-9adc-dc3407467c1e|Co-infection;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89;GP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis C;GP0|#76668c93-9a35-43ee-918b-a18a40ef5c30;L0|#076668c93-9a35-43ee-918b-a18a40ef5c30|Liver CancerGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa42016-12-19T04:38:21Z
    HCV New Treatments Quick Reference Toolhttp://www.ashm.org.au/resources/Pages/978-1-920773-46-5.aspxHCV New Treatments Quick Reference ToolThis two-page quick reference guide assists health professionals to decide which new direct acting antiviral hepatitis C treatment regimen is most appropriate for their patient. GP0|#9ac742b4-1677-49fd-9f7a-c0e73d2957b5;L0|#09ac742b4-1677-49fd-9f7a-c0e73d2957b5|Decision Making Tool;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#a700ed02-fbb9-4529-9868-7e249cd119ecGP0|#f001df20-76bd-422b-9adc-dc3407467c1e;L0|#0f001df20-76bd-422b-9adc-dc3407467c1e|Co-infection;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89;GP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis C;GP0|#76668c93-9a35-43ee-918b-a18a40ef5c30;L0|#076668c93-9a35-43ee-918b-a18a40ef5c30|Liver CancerGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa42016-08-08T22:00:34Z
    Primary Care Providers and Hepatitis Chttp://www.ashm.org.au/resources/Pages/978-1-920773-42-7.aspxPrimary Care Providers and Hepatitis CThis booklet for Primary Care Providers includes information on the hepatitis C virus, the natural history of HCV, a straightforward 12 step plan for the management of HCV and treatment protocols with the new direct acting antiviral (DAAs) medications.GP0|#dcb5bb65-47fe-4de8-bef4-63504a92e3d3;L0|#0dcb5bb65-47fe-4de8-bef4-63504a92e3d3|Booklet;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#a700ed02-fbb9-4529-9868-7e249cd119ecGP0|#f001df20-76bd-422b-9adc-dc3407467c1e;L0|#0f001df20-76bd-422b-9adc-dc3407467c1e|Co-infection;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89;GP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis CGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa42016-08-26T05:28:17Z
    2014 Second National Hepatitis B Mapping Reporthttp://www.ashm.org.au/resources/Pages/1976963416.aspx2014 Second National Hepatitis B Mapping ReportThe Hepatitis B Mapping project aims to facilitate a comprehensive understanding of chronic hepatitis B (CHB) in Australia.GP0|#d42dd495-5b19-42d7-8a04-0b1e1d76e4a2;L0|#0d42dd495-5b19-42d7-8a04-0b1e1d76e4a2|Report;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#a700ed02-fbb9-4529-9868-7e249cd119ecGP0|#8ab7205f-9a3e-4243-b625-fa0c0db6a04c;L0|#08ab7205f-9a3e-4243-b625-fa0c0db6a04c|Hepatitis B;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89GP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa42015-06-17T01:12:26Z
    Decision Making in HIVhttp://www.ashm.org.au/resources/Pages/1976963400.aspxDecision Making in HIVThis two-page quick reference guide assists health professionals to evaluate HIV laboratory results and can be used when making decisions about HIV management.GP0|#9ac742b4-1677-49fd-9f7a-c0e73d2957b5;L0|#09ac742b4-1677-49fd-9f7a-c0e73d2957b5|Decision Making Tool;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#a700ed02-fbb9-4529-9868-7e249cd119ecGP0|#dd9963c0-8c72-40e7-83e9-94fb06eb72f5;L0|#0dd9963c0-8c72-40e7-83e9-94fb06eb72f5|HIV;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89GP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa42016-10-23T20:14:27Z


    ​​​

    Please enter a valid E-mail.
    This must match your colleagues E-mail.
    Please enter your name.
    Please enter a valid email.
    This must match your email.